|
Market Cap (17-May) $40,671,720 (1,053rd) |
Close (30-Jun) $0.125 |
Volume (30-Jun) 400,697 |
Shortsold (10-Dec) 1,128,575 (0.62%) (255th) |
|
52w High $0.345 |
52w Low $0.140 |
P/E - |
EPS -0.05 |
CYP released this announcement to the ASX on 27 July 2022, 12:19. The announcement is marked as price sensitive, and is 9 page(s) in length and 479.1kb in size.
You can view all announcements from CYP and see how they appear on a price chart on the announcements page.
At the date of this announcement, CYP was 0.003% short sold according to ASIC data. It was ranked the 613th most shorted stock on the ASX. It is now ranked as the 255th most shorted stock on the ASX with 0.624% of total shares short sold as of the latest reported data (10 December 2024).
| Other Recent Announcements from CYP | |
|---|---|
| Notification regarding unquoted securities - CYP | 30 June 2023, 13:10 |
| Proposed issue of securities - CYP | 30 June 2023, 9:44 |
| Cynata announces CEO succession and Board changes | 30 June 2023, 9:13 |
| Quarterly Activity Report & Appendix 4C | 27 July 2022, 12:19 |
| Notice of Allowance for Cynata US Patent | 14 July 2022, 8:55 |
| Further data supports potency of Cynata MSCs | 14 June 2022, 9:12 |
| Cynata Adds New Site for MEND Clinical Trial | 30 May 2022, 9:16 |
You must be logged in to post a reply.
Cynata Therapeutics 